Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in PVLA held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | SUVRETTA CAPITAL MANAGEMENT, LLC | 1.2M | $143.8M | +29.3% | 9.745% | 3.90% |
| 2 | First Light Asset Management, LLC | 981K | $122.3M | +38.3% | 8.285% | 10.96% |
| 3 | BVF INC/IL | 961K | $119.8M | +9.3% | 8.118% | 3.82% |
| 4 | Frazier Life Sciences Management, L.P. | 882K | $110.0M | +22.1% | 7.454% | 2.83% |
| 5 | BlackRock, Inc. | 687K | $85.6M | +22.9% | 5.802% | 0.00% |
| 6 | JENNISON ASSOCIATES LLC | 641K | $79.9M | +65.3% | 5.412% | 0.05% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 477K | $59.5M | β | 4.032% | 0.00% |
| 8 | STATE STREET CORP | 459K | $57.2M | +9.2% | 3.877% | 0.00% |
| 9 | FEDERATED HERMES, INC. | 433K | $54.0M | +17.6% | 3.658% | 0.09% |
| 10 | FRONTIER CAPITAL MANAGEMENT CO LLC | 374K | $46.6M | β | 3.160% | 0.48% |
| 11 | Woodline Partners LP | 318K | $39.6M | +5.7% | 2.682% | 0.15% |
| 12 | Siren, L.L.C. | 257K | $32.1M | +243.3% | 2.175% | 0.89% |
| 13 | EVENTIDE ASSET MANAGEMENT, LLC | 233K | $29.0M | +129.2% | 1.970% | 0.48% |
| 14 | ALLIANCEBERNSTEIN L.P. | 263K | $27.5M | -2.3% | 2.220% | 0.01% |
| 15 | FMR LLC | 216K | $26.9M | -6.9% | 1.823% | 0.00% |
| 16 | MPM Oncology Impact Management LP | 206K | $25.7M | +0.3% | 1.744% | 1.99% |
| 17 | GEODE CAPITAL MANAGEMENT, LLC | 206K | $25.6M | +14.9% | 1.737% | 0.00% |
| 18 | PRIMECAP MANAGEMENT CO/CA/ | 195K | $24.3M | β | 1.648% | 0.02% |
| 19 | GOLDMAN SACHS GROUP INC | 194K | $24.2M | +96.3% | 1.640% | 0.00% |
| 20 | Artisan Partners Limited Partnership | 194K | $24.2M | -8.4% | 1.637% | 0.04% |
| 21 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 193K | $24.0M | β | 1.630% | 0.00% |
| 22 | ORBIMED ADVISORS LLC | 185K | $23.0M | β | 1.559% | 0.48% |
| 23 | Alyeska Investment Group, L.P. | 180K | $22.4M | β | 1.520% | 0.06% |
| 24 | EMERALD ADVISERS, LLC | 162K | $20.1M | β | 1.364% | 0.64% |
| 25 | First Turn Management, LLC | 148K | $18.5M | β | 1.251% | 2.06% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in PVLA β a direct measure of their conviction.
Filings activity in PVLA during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new PVLA position in Q1 2026
Institutions that fully closed their PVLA position in Q1 2026
6 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 181 | +30% | 125.74% | +46.51 pp | $1.62B | +59% |
| Q4 2025 | 139 | +40% | 79.23% | +37.65 pp | $1.02B | +91% |
| Q3 2025 | 99 | +50% | 41.58% | +31.25 pp | $536M | +303% |
| Q2 2025 | 66 | +57% | 10.33% | 0.81 pp | $133M | 7.3% |
| Q1 2025 | 42 | +24% | 11.14% | +7.38 pp | $143M | +196% |
| Q4 2024 | 34 | β | 3.76% | β | $48M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying PVLA stock.
Based on Q1 2026 13F filings, institutional ownership of Palvella Therapeutics, Inc. stands at 125.7%, held across 181 reporting institutions.
SUVRETTA CAPITAL MANAGEMENT, LLC is the largest reported institutional holder of PVLA, with approximately 1,153,496 shares worth $0.14B as of Q1 2026.
Yes β 1 widely-followed marquee investor appear among the top 25 institutional holders of PVLA, including SUSQUEHANNA INTERNATIONAL GROUP, LLP.
Our composite Smart Money Score for PVLA is 70 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
68 institutions opened new positions in PVLA during Q1 2026, while 26 fully exited. 97 added to existing positions and 16 trimmed.
PVLA institutional ownership rose by 46.51 percentage points quarter-over-quarter, with a net change of +42 holders.
The top 10 institutions account for 54.2% of all reported 13F value in PVLA, and the top 25 account for 78.2%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Palvella Therapeutics, Inc. (PVLA) Institutional Ownership